Enhancing transdermal delivery of chrysomycin A for the treatment of cutaneous melanoma and MRSA infections using Skin-Penetrating Peptide-Functionalized deformable liposomes.

RPEP-102812025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Enhancing transdermal delivery of chrysomycin A for the treatment of cutaneous melanoma and MRSA infections using Skin-Penetrating Peptide-Functionalized deformable liposomes.
Published In:
International journal of pharmaceutics, 670, 125130 (2025)
Database ID:
RPEP-10281

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-10281·https://rethinkpeptides.com/research/RPEP-10281

APA

Cai, Yue; Zhang, Xinrui; Hu, Wentao; Song, Fuhang; Wang, Hong; Zhang, Huawei; Sun, Xuanrong. (2025). Enhancing transdermal delivery of chrysomycin A for the treatment of cutaneous melanoma and MRSA infections using Skin-Penetrating Peptide-Functionalized deformable liposomes.. International journal of pharmaceutics, 670, 125130. https://doi.org/10.1016/j.ijpharm.2024.125130

MLA

Cai, Yue, et al. "Enhancing transdermal delivery of chrysomycin A for the treatment of cutaneous melanoma and MRSA infections using Skin-Penetrating Peptide-Functionalized deformable liposomes.." International journal of pharmaceutics, 2025. https://doi.org/10.1016/j.ijpharm.2024.125130

RethinkPeptides

RethinkPeptides Research Database. "Enhancing transdermal delivery of chrysomycin A for the trea..." RPEP-10281. Retrieved from https://rethinkpeptides.com/research/cai-2025-enhancing-transdermal-delivery-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.